https://doi.org/10.4081/mem.2023.1245

Deactivating permanent pacemakers in pacemakerdependent patients with terminal illness: an ethical perspective

Vol. 72 No. 3 (2023)
Published: October 27, 2023
end-of-life issues, health care delivery, decision making, cardiovascular implantable electronic devices, replacement therapy, substitutive therapy, professional virtues
Abstract Views: 623
PDF: 14
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Jaime Hernandez-Ojeda
jaheroj@gmail.com
School of Theology, Department of Moral Theology, Pontifical University of the Holy Cross, Rome, Italy.
Pablo Requena
Pontifical Academy for Life, Rome; Clinical Ethics Commission, Baby Jesus Pediatric Hospital, Rome, Italy.

Medical guidelines state that both implantable cardioverter defibrillator (ICD) and pacemaker deactivation may be ethically permissible when the patient requests their withdrawal based on the respect for the patient's autonomy. However, they also state that most physicians make an ethical distinction between deactivating ICDs and deactivating permanent pacemakers in pacemaker-dependent patients, being reasonably uncomfortable when confronted with a petition for pacing deactivation in these patients. If a difference between both actions exists, what principles explain this ethical distinction? We analyze this question from the perspective of the bioethical principles and the standpoint of the distinction between substitution and replacement therapies for ethical decisions. Even if we recognize appropriate insights in these proposals, they are insufficient to provide an adequate ethical justification in case of pacemaker deactivation in pacemaker-dependent patients. We propose the burden of therapy and the configuration of the moral act as determinant factors in arriving at a solid answer. In these cases, it is necessary to arrive at a description as precise as possible of the moral action that is performed and to ask what is the basic intentionality that moves such action. Furthermore, we propose the communication virtues as an important aspect to practice in cases of request of a pacemaker withdrawal.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Hernandez-Ojeda, J., & Requena, P. (2023). Deactivating permanent pacemakers in pacemakerdependent patients with terminal illness: an ethical perspective. Medicina E Morale, 72(3), 313–327. https://doi.org/10.4081/mem.2023.1245

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.